Seattle Genetics Inc. (SGEN) Tops Q1 EPS by 1c

Seattle Genetics Inc. (NASDAQ: SGEN) reported Q1 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $52.33 million.

For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Benchmark initiates Synopsys, Cadence with Buy ratings on AI-driven EDA outlook
• TSMC (2330:TT) (TSM) PT Raised to NT$3,200 at KGI Securities, 'Still top of the class, but investors may expect more'
• HSBC upgrades India, sticks with China as Asia’s AI rally faces reality check